InnovaRx Innova Health Strategies
Pricing Sign in

canakinumab

RxCUI 853491 ingredient

Contraindicated with · 5

Chemically-Induced Disorders Disease Diseases, Life Phases, Behavior Mechanisms and Physiologic States Drug Hypersensitivity Drug-Related Side Effects and Adverse Reactions

Indicated for · 44

Arthritis Arthritis, Juvenile Autoimmune Diseases Blood Protein Disorders Brain Diseases Brain Diseases, Metabolic Brain Diseases, Metabolic, Inborn Central Nervous System Diseases Chronic Disease Chronic Inducible Urticaria Chronic Urticaria Cold Urticaria Congenital, Hereditary, and Neonatal Diseases and Abnormalities Connective Tissue Diseases Cryopyrin-Associated Periodic Syndromes Disease Disease Attributes Diseases, Life Phases, Behavior Mechanisms and Physiologic States Familial Mediterranean Fever Genetic Diseases, Inborn Hematologic Diseases Hemic and Lymphatic Diseases Hereditary Autoinflammatory Diseases Hypergammaglobulinemia Hypersensitivity Hypersensitivity, Immediate Immune System Diseases Immunoproliferative Disorders Joint Diseases Metabolic Diseases Metabolism, Inborn Errors Mevalonate Kinase Deficiency Musculoskeletal Diseases Nervous System Diseases Nutritional and Metabolic Diseases Pathological Conditions, Signs and Symptoms Pathologic Processes Peroxisomal Disorders Rheumatic Diseases Skin and Connective Tissue Diseases Skin Diseases Skin Diseases, Genetic Skin Diseases, Vascular Urticaria